hVIVO

About hVIVO

hVIVO plc is a contract research organisation specializing in the testing of infectious and respiratory disease vaccines and antivirals using human challenge clinical trials. The company provides end-to-end early clinical development services, including laboratory services such as assay development, cell-based assays, compound efficacy testing, field trial bio-logistics, molecular and biomarker analysis. Its portfolio includes human challenge study models for conditions like RSV, influenza, COVID-19, hMPV, HRV, asthma, malaria, and COPD. hVIVO serves pharmaceutical and biotech organizations worldwide, supporting pre-clinical and clinical drug and vaccine discovery and development.